CPRX Brian Elsbernd sells $402K worth of shares
Sep 06, 2025, 4:35 AM
0.00%
What does CPRX do
Catalyst Pharmaceuticals, based in Coral Gables, Florida, develops and commercializes novel medicines for rare diseases, including FIRDAPSE for Lambert-Eaton Myasthenic Syndrome and AGAMREE for Duchenne Muscular Dystrophy. The company, which went public in 2006, employs 167 people.
Brian Elsbernd sold 20,000 shares of CPRX on 3 September at $20.08 per share, worth a total of $402K. They now own 188,564 CPRX shares, or a 10% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.